Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cutuli, Deboraa; c | Foti, Francescaa; c | Mandolesi, Lauraa; b | De Bartolo, Paolaa; c | Gelfo, Francescaa; b | Federico, Francescaa; d | Petrosini, Lauraa; c; *
Affiliations: [a] IRCCS Santa Lucia Foundation, Rome, Italy | [b] University of Naples “Parthenope”, Naples, Italy | [c] Department of Psychology, University of Rome “La Sapienza”, Rome, Italy | [d] University of Siena, Siena, Italy
Correspondence: [*] Corresponding author: Prof. Laura Petrosini, Department of Psychology, University of Rome “La Sapienza”, Via dei Marsi 78, 00185 Rome, Italy. Tel./Fax: +39 0649917522; E-mail: [email protected].
Abstract: Since acute and chronic administration of the acetylcholinesterase inhibitors, namely donepezil, improves cognitive functions in patients afflicted by mild to moderate dementia and reverses memory deficits in experimental models of learning and memory, it seemed interesting to assess the effects of chronic donepezil treatment on cognitive functions in adult rats with forebrain cholinergic depletion. Lesions were performed by means of intracerebroventricular injections of the immunotoxin 192 IgG-saporin. The cognitive functions of lesioned animals treated or not treated with donepezil were compared with those of intact animals. Cholinergic depletion affected working memory functions, weakened procedural competencies, affected the acquisition of localizing knowledge, and evoked remarkable compulsive and perseverative behaviors. In lesioned animals, chronic donepezil treatment ameliorated localizatory capabilities, performances linked to cognitive flexibility and procedural abilities. Furthermore, it attenuated compulsive deficits. The present data indicate positive effects of chronic donepezil treatment on specific cognitive performances, suggesting that an aimed use of acetylcholinesterase inhibitors, targeting some symptoms more than others, may be beneficial in the case of cholinergic hypofunction. The animal model used in the present research may provide an efficient method for analyzing cognition-enhancing drugs before clinical trials.
Keywords: Acetylcholinesterase inhibitor, behavioral testing, cholinergic neurotransmission, cognitive flexibility, forebrain cholinergic system, 192 IgG-saporin, mnesic functions
DOI: 10.3233/JAD-2009-1040
Journal: Journal of Alzheimer's Disease, vol. 17, no. 1, pp. 161-176, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]